Projected Price to Earnings: Profound Medical (PROF)

Profound Medical Corp. (PROF) develops MRI-guided ultrasound tumor therapy systems while adhering to environmental standards during assembly and packaging. The price indicator on the GURU.Markets platform chart shows a value of 0.00, visualizing market dynamics. Meanwhile, top management is focused on launching an innovative prostate treatment method into the global market, consistently expanding its clinical base and obtaining the necessary certifications.

Profound Medical Corp. - PROF Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/10/2026)

Metric breakdowns and analytics for Profound Medical Corporation (PROF)

- stock quotes and analyst forecast:

Stock Price Profound Medical Corp.|PROF - Average Forecast Price

- company stock exchange capitalization indicators:

Market Valuation Profound Medical Corp|PROF - Enterprise Value

- issuer book value statistics:

Accounting Value per Share Profound Medical|PROF - Total Net Assets|Market Capitalization to Book Value Ratio profoundmedical.com|PROF - Company Total Asset Base

- company liabilities and liquidity data:

Total Debt to Capital Profound Medical Corp.|PROF - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Profound Medical Corp.|PROF - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Profound Medical Corp|PROF - Company Long-Term Liabilities|Company Short-Term Debts Profound Medical|Quick Ratio profoundmedical.com

- financial results and valuation multiples details:

PROF - Company Profit|Projected Future Earnings Profound Medical Corp.|PROF - Business Payback Period|Forward P/E Multiple Profound Medical Corp.|PROF - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Profound Medical Corp|PROF - Operating profit EBITDA|Earnings per share for the last twelve months Profound Medical|PROF - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months profoundmedical.com|PROF - Earnings per share increase in current year|Earnings growth forecast for next year Profound Medical Corp.

Fundamental valuation:PROF Profound Medical

The forward P/E ratio compares the current market value of a share with the expected earnings for the future period. This multiple measures the cost per unit of profit that an investor is willing to pay today. By analyzing the current forward P/E of Profound Medical Corp. (PROF), one can assess market expectations regarding the commercialization of the TULSA-PRO system. High FDA barriers and patent protection make these forecasts sensitive to regulatory risks. The dynamics of this indicator determine the fair balance between the asset's value and its long-term potential.

Competitors of Profound Medical Corp.